# Palatin Technologies Inc. (PTN)

Source: https://www.quantisnow.com/company/PTN
Generated: 2026-11-17T15:22:54.244Z

- Ticker: PTN
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- SEC CIK: 0000911216
- Website: palatin.com

## About

Palatin Technologies, Inc., a specialized biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor agonist for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder. It is also developing oral PL8177, a selective melanocortin receptor (MCr) 1 agonist peptide that has completed Phase I clinical trial for the treatment of inflammatory bowel diseases; and systemic PL8177, which has completed Phase I clinical trial for treating non-infectious uveitis and COVID-19. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease; and melanocortin peptides for diabetic retinopathy. Further, it is developing PL3994, a natriuretic peptide receptor (NPR)-A agonist and synthetic mimetic of the endogenous neuropeptide hormone atrial natriuretic peptide for cardiovascular indications; and PL5028, a dual NPR-A and NPR-C agonist to treat cardiovascular and fibrotic diseases, including reducing cardiac hypertrophy and fibrosis. The company was founded in 1986 and is based in Cranbury, New Jersey.

## Latest PTN news and filings

- 2026-11-17 12:30 UTC [Earnings] [Palatin Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update](https://www.quantisnow.com/insight/palatin-reports-fiscal-first-quarter-2027-financial-results-and-provides-6795672)
- 2026-11-17 01:58 UTC [SEC Schedule 13G] [SEC Form SCHEDULE 13G filed by Palatin Technologies Inc.](https://www.quantisnow.com/insight/sec-form-schedule-13g-filed-by-palatin-technologies-inc-6795275)
- 2026-11-16 21:31 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Palatin Technologies Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-palatin-technologies-inc-6794585)
- 2026-11-16 12:30 UTC [Palatin Technologies Presents Compelling Preclinical Data on Next-Generation MC4R-Selective Peptide Agonists at ObesityWeek® 2026](https://www.quantisnow.com/insight/palatin-technologies-presents-compelling-preclinical-data-on-next-generation-mc4r-selective-peptide-6792232)
- 2026-11-13 12:30 UTC [Earnings Date] [Palatin to Report First Quarter Fiscal Year 2027 Results](https://www.quantisnow.com/insight/palatin-to-report-first-quarter-fiscal-year-2027-results-6789343)
- 2026-11-06 12:35 UTC [Analyst Coverage Resumed] [H.C. Wainwright resumed coverage on Palatin Technologies with a new price target](https://www.quantisnow.com/insight/hc-wainwright-resumed-coverage-on-palatin-technologies-with-a-new-6778024)
- 2026-09-28 20:30 UTC [SEC Form 10-K] [SEC Form 10-K filed by Palatin Technologies Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-palatin-technologies-inc-6727850)
- 2026-09-28 11:30 UTC [Earnings Date] [Palatin Reports Fiscal Year 2026 Financial Results and Provides Business Update](https://www.quantisnow.com/insight/palatin-reports-fiscal-year-2026-financial-results-and-provides-business-6727092)
- 2026-08-05 20:30 UTC [SEC Form 4] [SEC Form 4 filed by Director Morris Arlene](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-morris-arlene-6665841)
- 2026-08-05 20:30 UTC [SEC Form 4] [SEC Form 4 filed by Director Prendergast John K A](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-prendergast-john-k-a-6665835)
- 2026-08-05 20:30 UTC [SEC Form 4] [SEC Form 4 filed by Director Dunton Alan W](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-dunton-alan-w-6665831)
- 2026-08-03 10:04 UTC [SEC Form 8-K] [Palatin Technologies Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits](https://www.quantisnow.com/insight/palatin-technologies-inc-filed-sec-form-8-k-submission-of-matters-6658506)
- 2026-07-17 20:15 UTC [SEC Form 4] [Executive VP and CFO/COO Wills Stephen T covered exercise/tax liability with 195 shares, decreasing direct ownership by 0.30% to 63,792 units (SEC Form 4) (withholding obligation)](https://www.quantisnow.com/insight/executive-vp-and-cfocoo-wills-stephen-t-covered-exercisetax-liability-6641073)
- 2026-07-17 20:15 UTC [SEC Form 4] [President and CEO Spana Carl covered exercise/tax liability with 294 shares, decreasing direct ownership by 0.45% to 64,899 units (SEC Form 4) (tax liability)](https://www.quantisnow.com/insight/president-and-ceo-spana-carl-covered-exercisetax-liability-with-294-6641072)
- 2026-06-25 20:15 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Palatin Technologies Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-palatin-technologies-inc-6615887)
- 2026-05-28 21:13 UTC [SEC Form CERT filed by Palatin Technologies Inc.](https://www.quantisnow.com/insight/sec-form-cert-filed-by-palatin-technologies-inc-6577725)
- 2026-05-28 20:07 UTC [SEC Form 8-A12B filed by Palatin Technologies Inc.](https://www.quantisnow.com/insight/sec-form-8-a12b-filed-by-palatin-technologies-inc-6577087)
- 2026-05-28 20:05 UTC [SEC Form 25 filed by Palatin Technologies Inc.](https://www.quantisnow.com/insight/sec-form-25-filed-by-palatin-technologies-inc-6577032)
- 2026-05-18 21:07 UTC [SEC Form 8-K] [Palatin Technologies Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/palatin-technologies-inc-filed-sec-form-8-k-regulation-fd-disclosure-6560890)
- 2026-05-18 20:00 UTC [Leadership Update] [Palatin to Begin Trading on Nasdaq Stock Exchange](https://www.quantisnow.com/insight/palatin-to-begin-trading-on-nasdaq-stock-exchange-6559961)
- 2026-05-15 12:04 UTC [SEC Form SCHEDULE 13G filed by Palatin Technologies Inc.](https://www.quantisnow.com/insight/sec-form-schedule-13g-filed-by-palatin-technologies-inc-6555813)
- 2026-05-13 21:00 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Palatin Technologies Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-palatin-technologies-inc-6551545)
- 2026-05-13 11:30 UTC [Earnings Date] [Palatin Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update](https://www.quantisnow.com/insight/palatin-reports-fiscal-third-quarter-2026-financial-results-and-provides-6549675)
- 2026-02-17 14:30 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Palatin Technologies Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-palatin-technologies-inc-6394881)
- 2026-02-17 12:30 UTC [Public Offering] [Palatin Reports Second Quarter Fiscal Year 2026 Financial Results and Provides Corporate Update](https://www.quantisnow.com/insight/palatin-reports-second-quarter-fiscal-year-2026-financial-results-and-6394244)
- 2026-01-02 21:30 UTC [SEC Form 4] [President and CEO Spana Carl covered exercise/tax liability with 321 shares, decreasing direct ownership by 0.50% to 64,377 units (SEC Form 4)](https://www.quantisnow.com/insight/president-and-ceo-spana-carl-covered-exercisetax-liability-with-321-6332367)
- 2026-01-02 21:30 UTC [SEC Form 4] [Executive VP and CFO/COO Wills Stephen T covered exercise/tax liability with 212 shares, decreasing direct ownership by 0.33% to 63,276 units (SEC Form 4)](https://www.quantisnow.com/insight/executive-vp-and-cfocoo-wills-stephen-t-covered-exercisetax-liability-6332366)
- 2025-12-29 21:30 UTC [SEC Form 4] [Executive VP and CFO/COO Wills Stephen T sold $9,461 worth of shares (565 units at $16.74), decreasing direct ownership by 0.88% to 63,488 units (SEC Form 4)](https://www.quantisnow.com/insight/executive-vp-and-cfocoo-wills-stephen-t-sold-9461-worth-6328708)
- 2025-12-19 21:30 UTC [SEC Form 8-K] [Amendment: Palatin Technologies Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/amendment-palatin-technologies-inc-filed-sec-form-8-k-submission-of-6323967)
- 2025-12-12 13:54 UTC [Analyst Coverage Initiated] [Laidlaw initiated coverage on Palatin Technologies with a new price target](https://www.quantisnow.com/insight/laidlaw-initiated-coverage-on-palatin-technologies-with-a-new-price-6313552)
- 2025-12-11 22:00 UTC [SEC Form 4] [President and CEO Spana Carl was granted 885 shares, increasing direct ownership by 1% to 64,698 units (SEC Form 4)](https://www.quantisnow.com/insight/president-and-ceo-spana-carl-was-granted-885-shares-increasing-6312830)
- 2025-12-11 22:00 UTC [SEC Form 4] [Director Dunton Alan W was granted 2,000 shares, increasing direct ownership by 17% to 14,081 units (SEC Form 4)](https://www.quantisnow.com/insight/director-dunton-alan-w-was-granted-2000-shares-increasing-direct-6312829)
- 2025-12-11 22:00 UTC [SEC Form 4] [Executive VP and CFO/COO Wills Stephen T was granted 770 shares, increasing direct ownership by 1% to 64,053 units (SEC Form 4)](https://www.quantisnow.com/insight/executive-vp-and-cfocoo-wills-stephen-t-was-granted-770-6312828)
- 2025-12-11 22:00 UTC [SEC Form 4] [SEC Form 4 filed by Director Morris Arlene](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-morris-arlene-6312827)
- 2025-12-11 22:00 UTC [SEC Form 4] [Director Prendergast John K A was granted 2,600 shares, increasing direct ownership by 21% to 15,102 units (SEC Form 4)](https://www.quantisnow.com/insight/director-prendergast-john-k-a-was-granted-2600-shares-increasing-6312826)
- 2025-12-03 12:47 UTC [Analyst Coverage Initiated] [Alliance Global Partners initiated coverage on Palatin Technologies with a new price target](https://www.quantisnow.com/insight/alliance-global-partners-initiated-coverage-on-palatin-technologies-with-a-6300717)
- 2025-11-18 22:18 UTC [SEC Form 4] [Executive VP and CFO/COO Wills Stephen T covered exercise/tax liability with 229 shares, decreasing direct ownership by 0.70% to 32,583 units (SEC Form 4)](https://www.quantisnow.com/insight/executive-vp-and-cfocoo-wills-stephen-t-covered-exercisetax-liability-6285623)
- 2025-11-18 22:17 UTC [SEC Form 4] [President and CEO Spana Carl covered exercise/tax liability with 345 shares, decreasing direct ownership by 1% to 33,113 units (SEC Form 4)](https://www.quantisnow.com/insight/president-and-ceo-spana-carl-covered-exercisetax-liability-with-345-6285617)
- 2025-11-13 12:30 UTC [Public Offering] [Palatin Reports First Quarter Fiscal Year 2026 Financial Results and Provides Corporate Update](https://www.quantisnow.com/insight/palatin-reports-first-quarter-fiscal-year-2026-financial-results-and-6276116)
- 2025-11-12 17:15 UTC [Public Offering] [Palatin Technologies Announces Closing of Upsized $18.2 Million Public Offering with the Full Exercise of the Underwriters' Over-Allotment Option](https://www.quantisnow.com/insight/palatin-technologies-announces-closing-of-upsized-182-million-public-offering-6273725)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/PTN
- Earnings history: https://www.quantisnow.com/earnings/PTN
- Dividend history: https://www.quantisnow.com/dividends/PTN
- Insider transactions: https://www.quantisnow.com/insiders/PTN
- Options chain: https://www.quantisnow.com/options/PTN
- SEC 8-K filings only: https://www.quantisnow.com/company/PTN/8-k
- RSS and alerts for PTN: https://www.quantisnow.com/docs/rss-feeds.md
